InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
T+90 hit rate
59%
T+90 mean return
+5.8%
Across 22 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Gibson Christopher, Chairman & CEO. Director active across 2 companies, notably Recursion Pharmaceuticals, INC.. Cumulatively, 110 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €1.1m. Activity tracked since 21 November 2021. The latest transaction was filed on 22 May 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations110 total
40,000 shares0Class A Common StockSEC:0001856369-26-000019:0
40,000 shares@ US$3.080.0049% mcap2.3% of flowClass A Common StockSEC:0001856369-26-000019:1
40,000 shares0Class A Common StockSEC:0001856369-26-000013:0
40,000 shares@ US$3.610.0069% mcap2.6% of flowClass A Common StockSEC:0001856369-26-000013:1
57,473 shares0Common StockSEC:0001856369-26-000010:0
40,000 shares0Class A Common StockSEC:0001856369-26-000008:0
40,000 shares@ US$3.102.2% of flowClass A Common StockSEC:0001856369-26-000008:1
40,000 shares0Class A Common StockSEC:0001601830-26-000052:0
20,000 shares0Class A Common StockSEC:0001601830-26-000049:0
53,913 shares0Common StockSEC:0001299130-26-000050:0
27,265 shares@ US$3.491.0% of flowClass A Common StockSEC:0001601830-26-000021:0
40,000 shares0Class A Common StockSEC:0001601830-26-000008:0
40,000 shares0Class A Common StockSEC:0001856369-26-000005:0
60,000 shares0Class A Common StockSEC:0001856369-26-000003:0
40,000 shares0Class A Common StockSEC:0001856369-25-000018:0
60,000 shares0Class A Common StockSEC:0001856369-25-000016:0
40,390 shares@ US$4.141.8% of flowClass A Common StockSEC:0001856369-25-000014:0
60,000 shares0Class A Common StockSEC:0001856369-25-000012:0
100,000 shares0Class A Common StockSEC:0001856369-25-000010:0
120,000 shares0Class A Common StockSEC:0001856369-25-000007:0
100,000 shares0Class A Common StockSEC:0001856369-25-000005:0
120,000 shares0Class A Common StockSEC:0001601830-25-000145:0
100,000 shares0Class A Common StockSEC:0001601830-25-000136:0
40,390 shares@ US$5.642.4% of flowClass A Common StockSEC:0001601830-25-000132:0
423,666 shares0Class A Common StockSEC:0001601830-25-000130:0
25 of 110 declarations
About Gibson Christopher
Gibson Christopher is Président-Directeur Général and a director of Recursion Pharmaceuticals, INC. and Pacific Biosciences of California, INC., both listed on XNAS. He has 110 filings in total, and across the 110 sampled filings between 2021-12-09 and 2026-05-27, the reported amounts show EUR 0 of buys and EUR 1114641 of sells, with filings of nature C.
